MedPath

The efficacy of a microwave device for treating axillary hyperhidrosis

Phase 3
Conditions
hyperhidrosis, microwave device, miraDry
088/088
Primary axillary hyperhidrosis
Registration Number
JPRN-jRCTs032180023
Lead Sponsor
amiki Takeshi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
32
Inclusion Criteria

Primary axillary hyperhidrosis

Exclusion Criteria

Secondary hyperhidrosis, Frey syndrome

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Comparison of sweating weight 24 weeks after treatment (1Pass vs 2Pass)
Secondary Outcome Measures
NameTimeMethod
The difference in maximum sweating weight of 1 pass / 2 pass during exercise at 24 weeks after treatment<br>Difference in perspiration of 1 pass / 2 pass 24 weeks after treatment with odor complications<br>Difference in adverse event occurrence rate between 1 pass and 2 pass during the research period
© Copyright 2025. All Rights Reserved by MedPath